Healthpeak Properties, Inc. (NYSE:DOC) Receives Average Rating of "Moderate Buy" from Analysts

Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) has received a consensus rating of "Moderate Buy" from the eleven ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $23.27.

DOC has been the subject of several recent analyst reports. Argus reaffirmed a "buy" rating and set a $25.00 price objective on shares of Healthpeak Properties in a report on Tuesday, April 29th. Scotiabank decreased their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a report on Monday, May 12th. Wall Street Zen downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday, May 1st. Wedbush cut their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Finally, Wells Fargo & Company reduced their price objective on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd.

Healthpeak Properties Stock Down 0.1%

Shares of DOC traded down $0.01 during trading hours on Thursday, hitting $17.50. 4,492,722 shares of the company were exchanged, compared to its average volume of 5,162,458. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The company has a market cap of $12.16 billion, a PE ratio of 50.00, a PEG ratio of 2.17 and a beta of 1.04. The firm's 50 day moving average is $17.74 and its 200-day moving average is $19.47. Healthpeak Properties has a 52 week low of $16.64 and a 52 week high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The firm had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. During the same quarter in the prior year, the business earned $0.45 earnings per share. The company's revenue was up 15.9% on a year-over-year basis. On average, equities research analysts forecast that Healthpeak Properties will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a dividend, which was paid on Friday, May 30th. Investors of record on Tuesday, May 20th were paid a $0.1017 dividend. This represents a yield of 7.05%. The ex-dividend date was Monday, May 19th. Healthpeak Properties's dividend payout ratio is 305.00%.

Insider Buying and Selling at Healthpeak Properties

In other news, Director Tommy G. Thompson purchased 5,700 shares of the business's stock in a transaction that occurred on Friday, May 9th. The stock was purchased at an average cost of $17.36 per share, with a total value of $98,952.00. Following the acquisition, the director now directly owns 138,513 shares of the company's stock, valued at approximately $2,404,585.68. This trade represents a 4.29% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director John T. Thomas purchased 4,200 shares of Healthpeak Properties stock in a transaction on Monday, April 28th. The stock was purchased at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director now owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. This represents a 0.52% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 29,764 shares of company stock worth $521,909 over the last three months. Company insiders own 0.23% of the company's stock.

Institutional Trading of Healthpeak Properties

Several large investors have recently added to or reduced their stakes in DOC. Principal Financial Group Inc. increased its holdings in Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock valued at $367,575,000 after purchasing an additional 17,314,572 shares in the last quarter. Norges Bank bought a new stake in shares of Healthpeak Properties during the fourth quarter worth $166,804,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Healthpeak Properties by 584.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock valued at $186,405,000 after buying an additional 7,872,150 shares in the last quarter. Nuveen LLC bought a new position in shares of Healthpeak Properties in the first quarter valued at about $124,113,000. Finally, Resolution Capital Ltd bought a new position in shares of Healthpeak Properties in the fourth quarter valued at about $122,795,000. 93.57% of the stock is owned by institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.